Ruling out mismatch repair leading to endometrial cancer, we found that MLH3 mutations are predominantly present in colorectal cancer patients in low-risk families, such as those in which two first-degree relatives have the disease, and that most of them are genetically inherited at low epistasis rather than a single highly pathogenic mutation. This evidence concerns the gene MLH3 and colorectal cancer.